stable coronary artery disease or peripheral artery disease
Cardiovascular · 2019–2019
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| rivaroxaban Prevention of recurrent cardiovascular events (composite of cardiovascular death, stroke, or myocardial infarction) in patients in the stable phase of coronary… | Mar 2019 | Not recommended | input received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.